Frank Butschbacher develops and executes effective investor relations and communications programs for life science companies, from start-up phase to clinical stage to mature corporation.

Our customers benefit from more than 15 years experience in the industry, including private and NASDAQ-listed biotech and Fortune 500 healthcare companies in Europe and the USA.

We secure consistent and relevant international coverage for your company’s news and messages. 
"A good idea well communicated can always be financed."
Richard F. Pops, BIO Board Member, Chairman Alkermes Inc.
return on communications